Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Evotec SE

Start price
Target price
Perf. (%)
€17.95
28.11.23
€28.00
28.11.25
2.06%
11.12.23

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€17.06
26.11.23
-
26.11.24
57.74%
09.12.23

Could be worthwhile Investment >10% per year
Bayer AG

Start price
Target price
Perf. (%)
€32.77
24.11.23
€35.00
21.12.23
-6.78%
29.11.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
buy
Bayer AG

Start price
Target price
Perf. (%)
€33.84
21.11.23
€35.00
21.12.23
-3.16%
24.11.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
buy
Bayer AG

Start price
Target price
Perf. (%)
€34.23
20.11.23
€42.00
20.11.24
-6.50%
07.12.23

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
buy
Bayer AG

Start price
Target price
Perf. (%)
€40.81
17.11.23
-
17.11.24
-29.66%
17.05.24

Bayer AG

Start price
Target price
Perf. (%)
€40.83
15.11.23
€35.00
15.11.24
-19.02%
22.11.23

Probably not worthwhile Investment
Higher risks for its business
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.32
15.11.23
€4.61
15.11.24
73.68%
08.03.24

Affimed N.V.

Start price
Target price
Perf. (%)
€0.31
13.11.23
-
13.11.24
78.39%
08.03.24

Affimed N.V.

Start price
Target price
Perf. (%)
€0.35
05.11.23
-
05.11.24
58.73%
08.03.24

buy
Bayer AG

Start price
Target price
Perf. (%)
€40.81
31.10.23
-
31.10.24
-18.31%
20.11.23

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
Affimed N.V.

Start price
Target price
Perf. (%)
€0.29
28.10.23
-
28.10.24
89.77%
08.03.24

Paion AG

Start price
Target price
Perf. (%)
€0.68
04.10.23
€0.000
04.10.24
-
11.04.23

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.45
25.09.23
€6.61
25.09.24
23.49%
08.03.24

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€29.49
12.09.23
-
12.09.24
35.54%
31.01.24

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.49
07.09.23
€6.54
07.09.24
12.95%
08.03.24

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.51
11.08.23
€4.56
11.08.24
9.18%
08.03.24

buy
Bayer AG

Start price
Target price
Perf. (%)
€52.39
07.08.23
€54.00
07.08.24
-35.42%
21.11.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€2.30
04.08.23
-
04.08.24
-25.00%
17.05.24

buy
Evotec SE

Start price
Target price
Perf. (%)
€23.86
20.07.23
€25.00
20.07.24
-42.60%
17.02.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Well known brand
buy
Bayer AG

Start price
Target price
Perf. (%)
€49.93
10.07.23
€55.00
10.07.24
-42.51%
17.05.24

Could be worthwhile Investment >10% per year
Biofrontera AG

Start price
Target price
Perf. (%)
€0.78
04.07.23
€0.000
04.07.24
-58.31%
13.05.24

Could be very worthwhile Investment >20% year
Undervalued
Medigene AG

Start price
Target price
Perf. (%)
€1.87
24.06.23
€1.00
24.06.24
-23.32%
17.05.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Bayer AG

Start price
Target price
Perf. (%)
€50.60
23.06.23
-
0.18%
23.06.23

Could be worthwhile Investment >10% per year
buy
Evotec SE

Start price
Target price
Perf. (%)
€21.94
16.06.23
€30.00
16.06.24
-2.28%
24.06.23